In posing these questions, the authors wisely let HIV-positive individuals speak for themselves. Klitzman, a psychiatrist, and Bayer, a medical ethicist and historian, draw on the responses of 77 participants in their study of serostatus disclosure decisions. The participants, most of whom are HIV-positive and who are heterogeneous in gender, race, and sexual orientation, were asked about their experiences disclosing HIV serostatus to partners, family members, friends, and colleagues; rationales for their decisions; and attitudes toward practices such as Tarasoff notifications and breaches of confidentiality by health care providers.